WHITEPAPERS

Virtual Audits:Finding opportunity in COVID-19 crisis

Qualification audits have always been routine events for life-science companies, such as pharmaceutical manufacturers. For companies that outsource their testing, audits — complete with onsite visits to laboratory facilities — are traditional practice in terms of maintaining Food and Drug Administration (FDA) compliance.

COVID-19’s emergence meant an alternate to the onsite qualification audits was needed. In a surefire case of good emerging from a bad situation, even further value developed from a new audit method.

But first: Why do we audit pharmaceutical-testing firms?

To continue reading, please fill out the form.

Whitepaper Request Form

9 + 7 =